Strains of Klebsiella pneumoniae producing extended spectrum beta-lactamases, isolated from organ recipients

Transplant Proc. 2011 Oct;43(8):3128-9. doi: 10.1016/j.transproceed.2011.08.003.

Abstract

Objective: The aims of this work were to define the effectiveness of identification of the extended-spectrum beta-lactamases (ESBL) phenotype, and to define the genotype of Klebsiella pneumoniae β-lactamase.

Materials and methods: We identified ESBL phenotypes in 110 strains of K pneumoniae isolated from samples from patients of transplantation wards, using the double-disk synergy test (DDST). For the chosen strains, polymerase chain reaction (PCR) was applied to detect genes determining SHV, CTX-M, and TEM.

Results: We showed synergism of clavulanic acid and investigated antibiotics including ceftazidime (89.1%), cefotaxime (80%), and aztreonam (82.7%) against ESBL-positive strains PCR revealed that TEM and CTX-M were present in 88.89% of strains.

Conclusions: The ESBL mechanism of resistance is frequent among K pneumoniae strains isolated from transplant recipients. Strains with simultaneous synthesis of more than one beta-lactamase predominated.

MeSH terms

  • Cross Infection / drug therapy
  • Cross Infection / etiology
  • Cross Infection / microbiology
  • DNA, Bacterial / genetics
  • Humans
  • Klebsiella Infections / drug therapy
  • Klebsiella Infections / etiology
  • Klebsiella Infections / microbiology*
  • Klebsiella pneumoniae / drug effects
  • Klebsiella pneumoniae / enzymology*
  • Klebsiella pneumoniae / genetics
  • Klebsiella pneumoniae / isolation & purification
  • Microbial Sensitivity Tests
  • Polymerase Chain Reaction
  • Transplants / adverse effects
  • Transplants / microbiology*
  • beta-Lactamases / biosynthesis*
  • beta-Lactamases / genetics

Substances

  • DNA, Bacterial
  • beta-Lactamases